Measles-mumps-rubella and other measles-containing vaccines do not increase the risk for inflammatory bowel disease

A case-control study from the vaccine safety datalink project

Robert Davis, Piotr Kramarz, Kari Bohlke, Patti Benson, Robert S. Thompson, John Mullooly, Steve Black, Henry Shinefield, Edwin Lewis, Joel Ward, S. Michael Marcy, Eileen Eriksen, Frank Destefano, Robert Chen

Research output: Contribution to journalArticle

86 Citations (Scopus)

Abstract

Context: A link between measles virus-containing vaccines and inflammatory bowel disease (IBD) has been suggested by recent studies. Objective: To address whether receipt or timing of measles-containing vaccine (MCV) increases risk for IBD. Design: A case-control study. Setting: Four large health maintenance organizations (HMOs) that are part of the Centers for Disease Control and Prevention's Vaccine Safety Datalink project. Patients or Other Participants: A total of 155 persons with codes from International Classification of Diseases, Ninth Revision specific for IBD, born between 1958 and 1989 and enrolled from birth to the onset of disease, were identified. Up to 5 controls were matched by sex, HMO, and birth year. Intervention: None. Main Outcome Measures: Risk for IBD, Crohn's disease, and ulcerative colitis. Results: Past vaccination was not associated with an increased risk for Crohn's disease (odds ratio [OR] for measles-mumps-rubella vaccine [MMR], 0.4; 95% confidence interval [CI], 0.08-2.0), ulcerative colitis (OR, 0.8; 95% CI, 0.18-3.56), or IBD (OR, 0.59; 95% CI, 0.21-1.68). Risk for IBD was not increased among children vaccinated who were younger than 12 months (OR for MMR, 0.61; 95% CI, 0.15-2.45) or aged 12 to 18 months (OR, 0.86; 95% CI, 0.28-2.59) relative to unvaccinated children. Children vaccinated with MMR who were older than 18 months were at significantly decreased risk for IBD (OR, 0.16; 95% CI, 0.04-068). Neither past vaccination nor age at vaccination with other MCV was associated with increased risk for Crohn's disease, ulcerative colitis, or IBD. Risk for Crohn's disease, ulcerative colitis, or IBD was not elevated in the time immediately following vaccination with either vaccine. Conclusions: Vaccination with MMR or other MCV, or the timing of vaccination early in life, did not increase the risk for IBD.

Original languageEnglish (US)
Pages (from-to)354-359
Number of pages6
JournalArchives of Pediatrics and Adolescent Medicine
Volume155
Issue number3
DOIs
StatePublished - Jan 1 2001

Fingerprint

Measles Vaccine
Mumps
Rubella
Measles
Inflammatory Bowel Diseases
Case-Control Studies
Vaccines
Safety
Measles-Mumps-Rubella Vaccine
Vaccination
Odds Ratio
Confidence Intervals
Ulcerative Colitis
Crohn Disease
Health Maintenance Organizations
Parturition
Measles virus
International Classification of Diseases
Centers for Disease Control and Prevention (U.S.)
Outcome Assessment (Health Care)

All Science Journal Classification (ASJC) codes

  • Pediatrics, Perinatology, and Child Health

Cite this

Measles-mumps-rubella and other measles-containing vaccines do not increase the risk for inflammatory bowel disease : A case-control study from the vaccine safety datalink project. / Davis, Robert; Kramarz, Piotr; Bohlke, Kari; Benson, Patti; Thompson, Robert S.; Mullooly, John; Black, Steve; Shinefield, Henry; Lewis, Edwin; Ward, Joel; Marcy, S. Michael; Eriksen, Eileen; Destefano, Frank; Chen, Robert.

In: Archives of Pediatrics and Adolescent Medicine, Vol. 155, No. 3, 01.01.2001, p. 354-359.

Research output: Contribution to journalArticle

Davis, R, Kramarz, P, Bohlke, K, Benson, P, Thompson, RS, Mullooly, J, Black, S, Shinefield, H, Lewis, E, Ward, J, Marcy, SM, Eriksen, E, Destefano, F & Chen, R 2001, 'Measles-mumps-rubella and other measles-containing vaccines do not increase the risk for inflammatory bowel disease: A case-control study from the vaccine safety datalink project', Archives of Pediatrics and Adolescent Medicine, vol. 155, no. 3, pp. 354-359. https://doi.org/10.1001/archpedi.155.3.354
Davis, Robert ; Kramarz, Piotr ; Bohlke, Kari ; Benson, Patti ; Thompson, Robert S. ; Mullooly, John ; Black, Steve ; Shinefield, Henry ; Lewis, Edwin ; Ward, Joel ; Marcy, S. Michael ; Eriksen, Eileen ; Destefano, Frank ; Chen, Robert. / Measles-mumps-rubella and other measles-containing vaccines do not increase the risk for inflammatory bowel disease : A case-control study from the vaccine safety datalink project. In: Archives of Pediatrics and Adolescent Medicine. 2001 ; Vol. 155, No. 3. pp. 354-359.
@article{d84cb0a6cfc24c9cb66af3bdbaead6de,
title = "Measles-mumps-rubella and other measles-containing vaccines do not increase the risk for inflammatory bowel disease: A case-control study from the vaccine safety datalink project",
abstract = "Context: A link between measles virus-containing vaccines and inflammatory bowel disease (IBD) has been suggested by recent studies. Objective: To address whether receipt or timing of measles-containing vaccine (MCV) increases risk for IBD. Design: A case-control study. Setting: Four large health maintenance organizations (HMOs) that are part of the Centers for Disease Control and Prevention's Vaccine Safety Datalink project. Patients or Other Participants: A total of 155 persons with codes from International Classification of Diseases, Ninth Revision specific for IBD, born between 1958 and 1989 and enrolled from birth to the onset of disease, were identified. Up to 5 controls were matched by sex, HMO, and birth year. Intervention: None. Main Outcome Measures: Risk for IBD, Crohn's disease, and ulcerative colitis. Results: Past vaccination was not associated with an increased risk for Crohn's disease (odds ratio [OR] for measles-mumps-rubella vaccine [MMR], 0.4; 95{\%} confidence interval [CI], 0.08-2.0), ulcerative colitis (OR, 0.8; 95{\%} CI, 0.18-3.56), or IBD (OR, 0.59; 95{\%} CI, 0.21-1.68). Risk for IBD was not increased among children vaccinated who were younger than 12 months (OR for MMR, 0.61; 95{\%} CI, 0.15-2.45) or aged 12 to 18 months (OR, 0.86; 95{\%} CI, 0.28-2.59) relative to unvaccinated children. Children vaccinated with MMR who were older than 18 months were at significantly decreased risk for IBD (OR, 0.16; 95{\%} CI, 0.04-068). Neither past vaccination nor age at vaccination with other MCV was associated with increased risk for Crohn's disease, ulcerative colitis, or IBD. Risk for Crohn's disease, ulcerative colitis, or IBD was not elevated in the time immediately following vaccination with either vaccine. Conclusions: Vaccination with MMR or other MCV, or the timing of vaccination early in life, did not increase the risk for IBD.",
author = "Robert Davis and Piotr Kramarz and Kari Bohlke and Patti Benson and Thompson, {Robert S.} and John Mullooly and Steve Black and Henry Shinefield and Edwin Lewis and Joel Ward and Marcy, {S. Michael} and Eileen Eriksen and Frank Destefano and Robert Chen",
year = "2001",
month = "1",
day = "1",
doi = "10.1001/archpedi.155.3.354",
language = "English (US)",
volume = "155",
pages = "354--359",
journal = "JAMA Pediatrics",
issn = "2168-6203",
publisher = "American Medical Association",
number = "3",

}

TY - JOUR

T1 - Measles-mumps-rubella and other measles-containing vaccines do not increase the risk for inflammatory bowel disease

T2 - A case-control study from the vaccine safety datalink project

AU - Davis, Robert

AU - Kramarz, Piotr

AU - Bohlke, Kari

AU - Benson, Patti

AU - Thompson, Robert S.

AU - Mullooly, John

AU - Black, Steve

AU - Shinefield, Henry

AU - Lewis, Edwin

AU - Ward, Joel

AU - Marcy, S. Michael

AU - Eriksen, Eileen

AU - Destefano, Frank

AU - Chen, Robert

PY - 2001/1/1

Y1 - 2001/1/1

N2 - Context: A link between measles virus-containing vaccines and inflammatory bowel disease (IBD) has been suggested by recent studies. Objective: To address whether receipt or timing of measles-containing vaccine (MCV) increases risk for IBD. Design: A case-control study. Setting: Four large health maintenance organizations (HMOs) that are part of the Centers for Disease Control and Prevention's Vaccine Safety Datalink project. Patients or Other Participants: A total of 155 persons with codes from International Classification of Diseases, Ninth Revision specific for IBD, born between 1958 and 1989 and enrolled from birth to the onset of disease, were identified. Up to 5 controls were matched by sex, HMO, and birth year. Intervention: None. Main Outcome Measures: Risk for IBD, Crohn's disease, and ulcerative colitis. Results: Past vaccination was not associated with an increased risk for Crohn's disease (odds ratio [OR] for measles-mumps-rubella vaccine [MMR], 0.4; 95% confidence interval [CI], 0.08-2.0), ulcerative colitis (OR, 0.8; 95% CI, 0.18-3.56), or IBD (OR, 0.59; 95% CI, 0.21-1.68). Risk for IBD was not increased among children vaccinated who were younger than 12 months (OR for MMR, 0.61; 95% CI, 0.15-2.45) or aged 12 to 18 months (OR, 0.86; 95% CI, 0.28-2.59) relative to unvaccinated children. Children vaccinated with MMR who were older than 18 months were at significantly decreased risk for IBD (OR, 0.16; 95% CI, 0.04-068). Neither past vaccination nor age at vaccination with other MCV was associated with increased risk for Crohn's disease, ulcerative colitis, or IBD. Risk for Crohn's disease, ulcerative colitis, or IBD was not elevated in the time immediately following vaccination with either vaccine. Conclusions: Vaccination with MMR or other MCV, or the timing of vaccination early in life, did not increase the risk for IBD.

AB - Context: A link between measles virus-containing vaccines and inflammatory bowel disease (IBD) has been suggested by recent studies. Objective: To address whether receipt or timing of measles-containing vaccine (MCV) increases risk for IBD. Design: A case-control study. Setting: Four large health maintenance organizations (HMOs) that are part of the Centers for Disease Control and Prevention's Vaccine Safety Datalink project. Patients or Other Participants: A total of 155 persons with codes from International Classification of Diseases, Ninth Revision specific for IBD, born between 1958 and 1989 and enrolled from birth to the onset of disease, were identified. Up to 5 controls were matched by sex, HMO, and birth year. Intervention: None. Main Outcome Measures: Risk for IBD, Crohn's disease, and ulcerative colitis. Results: Past vaccination was not associated with an increased risk for Crohn's disease (odds ratio [OR] for measles-mumps-rubella vaccine [MMR], 0.4; 95% confidence interval [CI], 0.08-2.0), ulcerative colitis (OR, 0.8; 95% CI, 0.18-3.56), or IBD (OR, 0.59; 95% CI, 0.21-1.68). Risk for IBD was not increased among children vaccinated who were younger than 12 months (OR for MMR, 0.61; 95% CI, 0.15-2.45) or aged 12 to 18 months (OR, 0.86; 95% CI, 0.28-2.59) relative to unvaccinated children. Children vaccinated with MMR who were older than 18 months were at significantly decreased risk for IBD (OR, 0.16; 95% CI, 0.04-068). Neither past vaccination nor age at vaccination with other MCV was associated with increased risk for Crohn's disease, ulcerative colitis, or IBD. Risk for Crohn's disease, ulcerative colitis, or IBD was not elevated in the time immediately following vaccination with either vaccine. Conclusions: Vaccination with MMR or other MCV, or the timing of vaccination early in life, did not increase the risk for IBD.

UR - http://www.scopus.com/inward/record.url?scp=0035096005&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035096005&partnerID=8YFLogxK

U2 - 10.1001/archpedi.155.3.354

DO - 10.1001/archpedi.155.3.354

M3 - Article

VL - 155

SP - 354

EP - 359

JO - JAMA Pediatrics

JF - JAMA Pediatrics

SN - 2168-6203

IS - 3

ER -